Apple Watch app gets FDA clearance for Parkinson’s care

An Apple Watch-based app from digital health startup h2o therapeutics that monitors patients with Parkinson’s disease has gotten 510(k) marketing clearance from the FDA.

Advertisement

The prescription mobile app Parky tracks Parkinson’s symptoms like tremors and dyskinesia in real time via the watch using Apple’s Movement Disorder Application Programming Interface.

The app shares the data with medical professionals to help them develop a clinical profile for patients outside the clinic and tailor treatment plans.

“We believe Parky will bring great value to the Parkinson’s disease community as an easily scalable and data-driven product,” h2o therapeutics founder Yagmur Selin Gulmus said in a Nov. 20 company news release.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Digital Health

Advertisement

Comments are closed.